Kawasaki, Japan

Fumihiko Yokoya

This inventor holds 1 USPTO granted patent. Top assignee: Ajinomoto Co., Ltd.. Active years: 2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Fumihiko Yokoya. Retrieved from https://idiyas.com/inventor/fumihiko-yokoya

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2007

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Fumihiko Yokoya: Innovator in Hepatitis Diagnosis

Introduction

Fumihiko Yokoya is a notable inventor based in Kawasaki, Japan. He has made significant contributions to the field of biotechnology, particularly in the diagnosis of hepatitis. His work focuses on the development of polypeptides that can aid in medical diagnostics.

Latest Patents

Yokoya holds a patent for "Polypeptides, use thereof and process for producing the same." This patent describes an isolated polypeptide that comprises the amino acid sequence of SEQ ID NO: 11. The expression of this polypeptide is significantly lower in human livers affected by hepatitis compared to healthy human livers. The detection of this polypeptide's expression in human liver can serve as a diagnostic tool for human hepatitis.

Career Highlights

Fumihiko Yokoya is associated with Ajinomoto Co., Ltd., a leading company in the food and biotechnology sectors. His work at Ajinomoto has allowed him to explore innovative solutions in health diagnostics, particularly related to liver diseases.

Collaborations

Yokoya has collaborated with esteemed colleagues such as Takami Maekawa and Hisao Fukuda. Their combined expertise has contributed to advancements in the understanding and diagnosis of hepatitis.

Conclusion

Fumihiko Yokoya's innovative work in the field of biotechnology, particularly his patent related to hepatitis diagnosis, showcases his commitment to improving medical diagnostics. His contributions are significant in the ongoing fight against liver diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…